Serstech is pleased to announce the appointment of Mattias Löfstrand as its new Financial Manager. He will join Serstech on December 1, 2026.

Mattias brings extensive experience in finance and accounting. He has worked as an Authorized Public Accountant at PwC, Group Financial Controller at ASSA ABLOY, and Financial Manager at JD Stenqvist. He holds a bachelor’s degree in business and economics from Lund University.

“Mattias brings valuable experience in financial management and accounting. He will play an important role as Serstech continues to grow,” says Stefan Sandor, CEO of Serstech.

For further information, please contact:

Stefan Sandor,

CEO, Serstech AB Phone: +46 739 606 067

Email: ss@serstech.com

or

Arve Nilsson,

Chairman of the Board, Serstech AB Phone: +45 40 35 82 65

Email: arve.nilsson@serstech.com

or visit: www.serstech.com

Certified advisor to Serstech is Svensk Kapitalmarknadsgranskning AB (SKMG).

About Serstech

Serstech delivers solutions for chemical identification and has customers around the world, mainly in the safety and security industry. Typical customers are customs, police authorities, security organizations and first responders. The solutions and technology are however not limited to security applications and potentially any industry using chemicals of some kind could be addressed by Serstech’s solution. Serstech’s head office is in Sweden and all production is done in Sweden.

Serstech is traded at Nasdaq First North Growth Market and more information about the company can be found at www.serstech.com

  • 48% confirmed overall response rate (ORR) with a 10.4-month median duration of response in the primary analysis population of 65 patients with platinum-resistant/refractory ovarian cancer 
  • 36% ORR with an 8.1-month median duration of response across all cohorts in the overall population of 168 evaluable patients
  • Data presented today as a late-breaking oral presentation at ENA 2026
  • Rezatapopt NDA submission for platinum-resistant/refractory ovarian cancer planned in first quarter of 2027

PRINCETON, N.J., Nov. 20, 2026 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule therapies targeting p53, today reported updated results from the pivotal Phase 2 portion of the PYNNACLE clinical trial of rezatapopt monotherapy in patients with TP53 Y220C-mutated advanced solid tumors.

The data presented include investigator-assessed efficacy across all tumor types, including the primary analysis population of 65 platinum-resistant/refractory ovarian cancer patients who received prior standard of care. In this group, the overall response rate (ORR) was 48%, with a median duration of response of 10.4 months. In the overall population across all cohorts among 168 evaluable patients, the ORR was 36% and the median duration of response was 8.1 months.

Results were presented today in a late breaking oral presentation by Alison M. Schram, M.D., Medical Oncologist at Memorial Sloan Kettering Cancer Center and PYNNACLE Study Investigator at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2026) in Barcelona, Spain.

“Patients with platinum-resistant ovarian cancer who have progressed on standard therapies have few treatment options,” said Dr. Schram. “In this heavily pretreated population, nearly half of patients with platinum-resistant/refractory ovarian cancer responded to rezatapopt, and those responses lasted a median of more than 10 months. These results support rezatapopt as a potential new targeted option for patients whose tumors harbor a TP53 Y220C mutation.”

“The primary analysis reinforces the consistent, durable activity of rezatapopt in patients with platinum-resistant ovarian cancer that has been observed throughout the study,” said Deepika Jalota, Pharm.D., Chief Development Officer of PMV Pharma. “For patients who have endured multiple rounds of chemotherapy, rezatapopt has the potential to be a single-agent, chemotherapy-free, once-daily oral option they can take at home. We expect to submit our NDA for accelerated approval in the first quarter of 2027.”

The Phase 2 clinical trial data as of a September 4, 2026 data cutoff date are summarized below:

Patient Population

  • The safety population consisted of 180 patients across tumor types, including 113 ovarian cancer patients, treated with at least one dose of rezatapopt 2000 mg once daily as monotherapy.
  • The efficacy population consisted of 168 patients, including 101 ovarian cancer patients, treated with at least one dose of rezatapopt as of the data cutoff date and either had ≥1 post-baseline tumor assessment or discontinued early.
  • In the overall population, patients received a median of 3 prior lines of systemic therapy (range: 0-9) and median age was 65 years (range: 33-91).
  • In the ovarian cancer cohort, 93% of patients had high-grade serous ovarian cancer and 97% had platinum-resistant/refractory disease, with a median of 4 prior lines of systemic therapy (range: 1-9).

Efficacy Results

  • Confirmed responses were observed in patients whose tumors were TP53 Y220C mutated and KRAS wild-type in eight tumor types including ovarian, lung, breast, endometrial, head and neck, colorectal, gallbladder cancers, and ampullary carcinoma.
    • In the primary analysis population of platinum-resistant/refractory ovarian cancer patients who had received prior standard of care, the investigator-assessed confirmed overall response rate (ORR) per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 was 48% (31/65 patients, including one CR and 30 PRs), with a 10.4-month median duration of response and an 83% disease control rate.
      • A biomarker analysis revealed that, among 50 patients with available ctDNA data, 90% (45/50) achieved a ≥50% reduction in ctDNA levels of the TP53 Y220C VAF within 3-6 weeks of starting rezatapopt which supports the on-target activity of rezatapopt.
    • In the ovarian cancer population, responses were observed regardless of additional TP53 alterations or other oncogenic alterations at baseline.
  • In the overall population across all cohorts, a 36% ORR (61/168 patients, including four complete responses [CR], 53 partial responses [PR], and four unconfirmed partial responses [uPR]), with a median time to response of 1.3 months and a median duration of response of 8.1 months was observed.
  • The cohort-specific ORRs were as follows:
    • Ovarian cancer: 45% ORR (45/101 patients, including four confirmed CRs, 37 confirmed PRs, and four uPRs)
    • Lung cancer: 21% confirmed ORR (4/19 patients)
    • Breast cancer: 17% confirmed ORR (3/18 patients)
    • Endometrial cancer: 45% confirmed ORR (5/11 patients)
    • Other solid tumors: 21% confirmed ORR (4/19 patients)

Safety Results

  • Treatment-related adverse events (TRAEs) were mostly Grade 1 or 2 with the most frequent TRAEs observed (>15%) being nausea, fatigue, blood creatinine increase, vomiting, AST increase, ALT increase and anemia. The rates of individual Grade 3 TRAEs were ≤7.2%.
  • Lab abnormalities were manageable and monitorable, with most cases being transient and reversible.
  • Eleven patients (6%), including seven ovarian cancer patients, discontinued treatment due to TRAEs.  
  • Rezatapopt continued to demonstrate a manageable safety profile.

About Rezatapopt

Rezatapopt (PC14586) is a first-in-class, small molecule, p53 reactivator designed to selectively bind to the pocket in the p53 Y220C mutant protein, restoring the wild-type tumor-suppressor function. The U.S. Food and Drug Administration granted Fast Track designation to rezatapopt for the treatment of patients with locally advanced or metastatic solid tumors with a p53 Y220C mutation and Orphan Drug Designation for the treatment of TP53 Y220C positive ovarian cancer, fallopian tube cancer, and primary peritoneal cancer.

About the PYNNACLE Clinical Trial

The ongoing Phase 1/2 PYNNACLE clinical trial is evaluating rezatapopt in patients with advanced solid tumors harboring a TP53 Y220C mutation. The primary objective of the Phase 1 portion of the clinical trial was to determine the maximum tolerated dose and recommended Phase 2 dose (RP2D) of rezatapopt when administered orally to patients. Safety, tolerability, pharmacokinetics, and effects on biomarkers were also assessed. The Phase 2 portion is a registrational, single arm, expansion basket clinical trial comprising five cohorts (ovarian, lung, breast, and endometrial cancers, and other solid tumors) with the primary objective of evaluating the efficacy of rezatapopt at the RP2D in patients with TP53 Y220C advanced solid tumors, conducted across approximately 70 sites.

For more information about the Phase 1/2 PYNNACLE clinical trial, refer to www.clinicaltrials.gov (NCT trial identifier NCT04585750).

About PMV Pharma

PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule therapies targeting p53. TP53 mutations are found in approximately half of all cancers. Our co-founder, Dr. Arnold Levine, established the field of p53 biology when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize more than four decades of p53 biology, PMV Pharma combines unique biological understanding with a pharmaceutical development focus. PMV Pharma is headquartered in Princeton, New Jersey. For more information, please visit www.pmvpharma.com.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding the Company’s future plans or expectations for rezatapopt, including the Company’s ability to obtain approval as a treatment option as a monotherapy, expectations regarding timing, enrollment status and success of the Phase 2 portion of the current clinical trial for rezatapopt and the timing of a filing of a New Drug Application (NDA) for platinum-resistant/refractory ovarian cancer, expected therapeutic benefits of rezatapopt including safety profile and potential efficacy and tolerability, the expectations and timing regarding receipt and disclosures of data results from clinical trials, and the adequacy of the efficacy and safety data from clinical trials to support the Company’s pursuit of regulatory approval of a NDA for platinum-resistant/refractory ovarian cancer. Any forward-looking statements in this statement are based on management’s current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. Risks that contribute to the uncertain nature of the forward-looking statements include: the success, cost, and timing of the Company’s product candidate development activities, including the successful filing of NDAs, and planned clinical trials, the Company’s ability to execute on its strategy and operate as a clinical stage company, the potential for clinical trials of rezatapopt or any future clinical trials of other product candidates to differ from preclinical, preliminary or expected results, maintenance by the Company of ODD status and related benefits for rezatapopt, the Company’s ability to fund operations, and the impact that a global pandemic, other public health emergencies or geopolitical tensions or conflicts may have on the Company’s clinical trials, supply chain, and operations, as well as those risks and uncertainties set forth in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the “SEC”) on March 6, 2026, the company’s Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2026, and its other filings filed with the SEC. All forward-looking statements contained in this press release speak only as of the date on which they were made. The Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

Contacts

Investors Contact:
Tim Smith
Senior Vice President, Head of Corporate Development and Investor Relations
investors@pmvpharma.com

Media Contact:
Kathy Vincent
Greig Communications
kathy@greigcommunications.com

COMPANY ANNOUNCEMENT NO. 58-2026
FLSmidth & Co. A/S
20 November 2026
Copenhagen, Denmark

FLSmidth & Co. A/S (FLSmidth) today announces that Sander Fynboe has been appointed interim Chief Financial Officer (CFO) and member of the Executive Leadership Team (ELT), effective immediately. Sander, currently Senior Vice President, Group Finance at FLSmidth, will assume the full responsibilities and decision-making authority of CFO until a permanent CFO is in place.

Sander brings more than 30 years of international finance and leadership experience across industry and banking, including more than 12 years with FLSmidth. He has held several senior positions within the Group, including CFO for the South America region and Head of Group Treasury. Prior to joining FLSmidth, he held senior positions at A.P. Moller – Maersk and Danske Bank. His expertise spans operational finance leadership, finance transformation, business partnering, capital markets, M&A and treasury.

“I am pleased that Sander has agreed to take on this responsibility. His extensive financial leadership experience and deep understanding of FLSmidth and our business will help ensure continuity and maintain focus on delivering our priorities,” says Toni Laaksonen, CEO of FLSmidth.

The search for a permanent CFO is ongoing, with the ambition of completing the process in the first half of 2027. Once concluded, the appointment will be communicated in a separate company announcement.


Contacts:

Investor Relations

Andreas Holkjær Sandager, +45 24 85 03 84, Andreas.HolkjaerSandager@FLSmidth.com
Mia Storlopare, +45 23 82 0382, Mia.Storlopare@FLSmidth.com

Media

Martin Sjostrand, +45 23 64 83 59, Martin.Sjostrand@FLSmidth.com


About FLSmidth

The world needs more minerals, and they are becoming harder to produce. FLS works alongside mining companies as their performance partner, helping them increase output, improve recovery and maximise uptime. Through full flowsheet technologies, aftermarket services and digital solutions, we improve productivity while reducing energy and water consumption, enabling more sustainable mining operations. www.fls.com

Attachment

DOVER, USA, Nov. 20, 2026 (GLOBE NEWSWIRE) — E-Power Inc. (“E-Power,” the “Company,” “we” or “our”) (NASDAQ: EPOW), a provider of advanced battery materials and AI Data Center (AIDC) microgrid solutions, today announced that its joint venture, Sunrise (Guizhou) New Energy Materials Co., Ltd. (“Sunrise Guizhou”), has been designated a national-level Specialized, Refined, Distinctive and Innovative (“Little Giant”) enterprise by China’s Ministry of Industry and Information Technology (“MIIT”) as part of the MIIT’s eighth batch of Little Giant designations. Sunrise Guizhou received notice of the designation on October 14, 2026 through the MIIT’s High-Quality SME Gradient Cultivation Platform.

The designation completes the national review process described in the Company’s press release of August 20, 2026, which announced that Sunrise Guizhou had passed provincial review by the Department of Industry and Information Technology of Guizhou Province and was one of 28 enterprises included in the province’s recommendation list for the eighth batch.

The Top Tier of China’s SME Cultivation System

The MIIT’s gradient cultivation system for high-quality small and medium-sized enterprises (“SMEs”) has three tiers: technology-based and innovative SMEs; specialized and sophisticated SMEs, recognized at the provincial level; and Little Giant enterprises, designated at the national level by the MIIT. Only enterprises that already hold provincial specialized and sophisticated SME status may apply for Little Giant designation. The program recognizes SMEs that focus on specific market segments, possess core technologies and strong innovation capabilities, and hold leading positions in their segments.

Applications for the eighth batch were assessed under the MIIT’s revised Measures for the Administration of Gradient Cultivation of High-Quality Small and Medium-Sized Enterprises, issued in January 2026. According to the MIIT’s notice to Sunrise Guizhou, the designation followed preliminary review and recommendation by local authorities, expert review, and internal deliberation by the MIIT. The MIIT’s review uses staged review, random assignment of experts and review tasks, and blind review, and cross-checks application data using data analysis tools. The designation is valid for three years, from July 1, 2026 through June 30, 2029.

Progression Through All Three Tiers

Sunrise Guizhou has advanced through each tier of the system. It was recognized as an innovative SME in April 2023 and as a specialized and sophisticated SME in July 2024, and in May 2025 it was designated a Guizhou Province Key Specialized and Sophisticated SME. The Little Giant designation places it in the system’s top tier.

Sunrise Guizhou manufactures graphite anode materials and develops next-generation anode materials, including silicon-carbon composites and hard carbon for sodium-ion batteries. It was certified as a National High-Tech Enterprise in 2023. In 2024, one of its projects was selected through the “Open Competition” (Jie Bang Gua Shuai) mechanism of an MIIT industrial foundation innovation program and passed final acceptance in December 2024. In May 2025, it received an Excellence Award at the 25th China Patent Awards, granted by the China National Intellectual Property Administration, and in 2026 it participated in drafting the national standard “Porous Carbon for Silicon-Based Anode Materials” (Plan No. 20262157-T-605).

“This designation completes the national review that followed Guizhou’s provincial recommendation earlier this year, and we see it as recognition of our Guizhou team’s long-standing focus on anode materials,” said Mr. Haiping Hu, the founder, CEO and Chairman of E-Power Inc. “Because the designation is reviewed every three years, we intend to keep earning it through continued investment in research, standards work and manufacturing quality.”

About E-Power Inc.

E-Power Inc., through its subsidiaries, joint venture and variable interest entity structure, is engaged in the manufacturing and sale of graphite anode material for lithium-ion batteries. Through its joint venture, the Company operates a plant in Guizhou Province, China, powered by electricity from renewable sources, which contributes to the plant’s competitive production costs and reduced environmental impact in the production of graphite anode material. Mr. Haiping Hu, the founder, CEO and Chairman of the Company, has been a pioneer in the graphite anode industry since 1999. The Company’s management team is composed of experts with years of experience and successful track records in the graphite anode industry. For further information, please visit the Company’s website at www.sunrisenewenergy.com.

Forward-looking statement

Certain statements in this press release regarding the Company’s future expectations, plans and prospects constitute forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements about plans, goals, objectives, strategies, future events, expected results, assumptions, the continued development and application of the data governance work described in this release, and any statements that are not historical facts. Words such as “may,” “will,” “plan,” “anticipate,” “should,” “believe,” “expect,” “estimate,” and similar words, shall be regarded as forward-looking statements. The award described in this release recognizes the competition entry and does not carry funding or commercial commitments. Due to various factors, the actual results may differ materially from the historical results or from those expressed or implied by these forward-looking statements. These factors include, but are not limited to, the Company’s strategic objectives, the Company’s future plans, market demand and user acceptance of the Company’s products or services, technological updates, economic trends, the Company’s reputation and brand, the impact of industry competition, relevant policies and regulations, China’s macroeconomic conditions, international market conditions, and other related risks and assumptions. In view of the above and other related reasons, we advise investors not to place undue reliance on these forward-looking statements, and we urge investors to visit the website of the United States Securities and Exchange Commission to review the Company’s filings for other factors that may affect the Company’s future operating results. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

For more information, please contact:

The Company: IR Department

Email: IR@sunrisenewenergy.com

Phone: +1 4084890472

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW

CALGARY, Alberta, Nov. 21, 2026 (GLOBE NEWSWIRE) — High Arctic ‎Overseas Holdings Corp. (TSXV: HOH) (“High Arctic” or the “Corporation”) has released its second quarter financial and operating results. The unaudited condensed interim consolidated financial statements (the “Financial Statements”) and management’s discussion & analysis (“MD&A”) for the quarter ended September 30, 2026, will be available on SEDAR+ at www.sedarplus.ca. All amounts are denominated in United States Dollars (“USD”), unless otherwise indicated.

The common shares of the Corporation began trading on the TSXV on August 16, 2024 under the trading symbol HOH.

Mike Maguire, Chief Executive Officer, commented on the Corporation’s third quarter of 2026 financial and operating results and outlook:

“There have been a lot of positive developments for High Arctic this quarter. First, we progressed the preparation of Rig 103 which subsequently, in October, commenced drilling the first well site of the current 4-well drilling campaign. I am also excited about the growth and diversification of customers in our Rental Equipment division, headlined by the refurbishment and shipment of a 100-bed camp to commence rental on a multi-year contract. Coupled with the traction that our Fire Services division has made in its short history and the opportunities in front of us as the authorised distributor of Atlas Copco products in PNG, we are well placed for increased activity in 2027 and beyond as major expansionary and new resource projects progress.

The PNG government has set a December 15, 2026 Final Investment Decision deadline on the Papua-LNG project concessions. With the change of operator to ExxonMobil confirmed, the table has been set for a Papua-LNG project FID in the coming weeks. This project is expected to be the first of several major natural resource projects that are anticipated to bring a decade of significant investment in PNG. We expect that other drilling activity including more exploration wells will follow, creating opportunities for our idle drilling rigs in the coming years.”

2026 Third Quarter Highlights

  • Remobilisation and reactivation activities for Rig 103 were safely and successfully conducted during the quarter, with drilling commencing in October 2026;
  • Refurbishment of a 100-bed camp facility was largely completed with delivery occurring in October 2026;
  • Severe dry weather conditions persisting through PNG impacted non-drilling services as rivers become impassable to freight transport;
  • Invested $1 million in our rental equipment growth and expansion;
  • Revenue and operating margin increased from $2.2 million to $5.5 million & 16.2% to 34.2% respectively compared to Q3 2025; and
  • Exit Q3 with a positive working capital position of $15.3 million available to support the continued ramp up of new activities and other strategic objectives.

In the above results discussion, the three months ended September 30, 2026 may be referred to as the “quarter” or “Q3 2026” and the comparative three months ended September 30, 2025 may be referred to as “Q3 2025”. References to other quarters may be presented as “QX 20XX” with X/XX being the quarter/year to which the commentary relates.

Business Strategy

Our business strategy focused on Papua New Guinea is underpinned by the following cornerstones:

  • Leveraging our core PNG planning and logistics capability to diversify ‎our service offerings; 
  • Deploying idle assets into profitable operations; 
  • Strengthening local content & participation in the PNG finance and investment communities; 
  • An established and efficient corporate structure; and 
  • Seeking opportunities to expand and root the business in the Australasian region. 

2026 Strategic Objectives

  • Relentless focus on safety excellence and quality service delivery; 
  • Grow the Equipment Rentals and Fire Services business offerings; 
  • Pursue pathways to return idle drilling assets into service; 
  • Maximize potential participation in future major Papua New Guinea projects; and 
  • Pursue expansionary transactions that increase shareholder value. 

RESULTS OVERVIEW

The following is a summary of select financial information of the Corporation:

    Three months ended Sept 30,
(thousands of USD except per share amounts)   2026 2025
Operating results
     
Revenue   5,467 1,983
Net income (loss)   411 (1,330)
Per share (basic)   $0.03 ($0.11)
Per share (diluted)(1)   $0.03 ($0.11)
Operating margin(2)   1,869 321
Operating margin as a % of revenue(2)   34.2% 16.2%
EBITDA(2)   830 (741)
EBITDA as a % of revenue(2)   15.2% (37.4%)
Per share (basic)   $0.07 ($0.06)
Per share (diluted)(1)   $0.06 ($0.06)
Adjusted EBITDA(2)   886 (648)
Adjusted EBITDA as a % of revenue(2)   16.2% (32.7%)
Per share (basic)   $0.07 ($0.05)
Per share (diluted)(1)   $0.07 ($0.05)
Operating income (loss)(2)   345 (1,239)
Per share (basic)   $0.03 ($0.10)
Per share (basic)   $0.03 ($0.10)
       
Cash flow:      
Cash used in operating activities   (283) (800)
Per share (basic)   ($0.02) ($0.06)
Per share (diluted)(1)   ($0.02) ($0.06)
Funds flow from (used in) operating activities(2)   914 (727)
Per share (basic)   $0.07 ($0.06)
Per share (diluted)(1)   $0.07 ($0.06)
Capital expenditures   1,230 (39)

(thousands of USD except per share amounts and shares outstanding)   As at Sept 30, 2026 As at Dec 31, 2025
Financial position:      
Working capital(2)   15,265 18,705
Cash and cash equivalents   7,939 11,954
Total assets   30,594 30,284
Shareholder’s equity   24,202 27,011
Per share(3)   $1.95 $2.17
Weighted average common shares outstanding (000’s)   12,326 12,432
Weighted average diluted shares outstanding (000’s)   12,326 12,432
Common shares outstanding (000’s)(3)   12,417 12,429

(1) For periods when the Corporation incurs a net loss or equivalent negative measure, certain potentially dilutive instruments were excluded from the calculation of diluted per share metrics as the inclusion would be anti-dilutive.
(2) Operating margin, EBITDA (Earnings before interest, tax, depreciation, and amortization), Adjusted EBITDA, Operating income (loss), Funds flow from operating activities and Working capital do not have a standardized meanings prescribed by IFRS. See “Non IFRS Measures” in the Corporation’s Q3 2026 MD&A for calculations of these measures.
(3) Shareholder’s equity per share calculated based on common shares outstanding as at the relevant date.

Operating Results

    Three months ended Sept 30,
(thousands of USD, unless otherwise noted)   2026 2025
Revenue   5,467 1,983
Operating expenses   (3,598) (1,662)
Operating margin(1)   1,869 321
Operating margin (%)   34.2% 16.2%

(4) See “Non-IFRS Measures” in the Corporation’s Q3 2026 MD&A for calculations of these measures.

Revenues totalled $5,467 for the three months ended September 30, 2026, compared to $1,983 for the comparative periods in 2025. The majority of Q3 2026 revenue is from activities associated with the reactivation of rig 103. The share of revenue from drilling services relative to revenue from equipment rental and fire services solutions will increase in the coming months as drilling moves from warm stack to operating. Customer-owned rig 103 was suspended from the second half of 2024 till Q2 2026.

The Corporation owns two heli-portable drilling rigs (Rigs 115 and 116) which remain preserved and maintained ready for deployment.

Liquidity and Capital Resources

    Three months ended Sept 30,
(thousands of USD)   2026 2025
Cash provided by (used in) operations:      
Operating activities   (283) (800)
Investing activities   (1,230) 39
Financing activities   (101) (88)
Effect of foreign exchange rate changes   (6) 2
(Decrease) in cash   (1,620) (847)

(thousands of USD, unless otherwise noted)   As at
Sept 30, 2026
As at
Dec 31, 2025
Current assets   21,224 21,978
Working capital(1)   15,265 18,705
Working capital ratio(1)   3.6:1 6.7:1
Cash and cash equivalents   7,939 11,954

 (1) See “Non-IFRS Measures”

Cash flows from Operating Activities
For the three months ended September 30, 2026, cash used in operating activities was $283 (Q3 2025 – $800). The change in operating cash flow was driven by a change in mix of revenue generating activities, cost of deploying assets into new markets, fixed costs associated with the Fire Services division establishing a market presence, costs associated with the commencement of the Atlas Copco distributorship, professional fees related to strategic activity, corporate services, equipment readiness and changes in non-cash working capital. Changes in non-cash working capital are listed in Note 13 of the Financial Statements and represent temporary differences as inventory previously purchased in support of anticipated sales and deferred revenue is earned.

Cash flows from Investing Activities
For the three months ended September 30, 2026, the Corporation’s cash used in investing activities was $1,230 (Q3 2025 – cash generated $39). The positive balance for Q3 2025 was the result of cost base adjustments to finalised capital projects and the actual cash outflows during that quarter was $30. Cash outflows associated with investing activities were directed towards capital expenditure on rental equipment assets. The increase in capital expenditures in 2026 is predominantly investment in rental equipment assets to supply increasing customer activity. The Corporation will continue to seek opportunities to invest in additional capital assets where there is strong market demand.

Cash flows from Financing Activities
For the three months ended September 30, 2026, the Corporation’s cash used in financing activities was $101 (Q3 2025 – $88). Cash outflows associated with finance activities were mainly directed towards lease obligation payments and share repurchases via Normal Course Issuer Bid program in Q3 2025. There are no share repurchases during the quarter.

Outlook

Entering Q4 of 2026, there are several developments that are leading to significant improvements in performance for High Arctic. These include the return to active drilling operations, deployment of a significant camp asset into long term service, expansion of the Fire Services customer base, the continued diversification of our rental equipment customer base in PNG, establishment of supply of Atlas Copco products under our sole distributorship in PNG and updated guidance for a Papua LNG final investment decision (“FID”) in Q4 2026.

Drilling Rig 103 was prepared and transported to the first wellsite of current campaign through Q3 2026, pursuant to the two-year contract extension with our principal customer in PNG. The Corporation completed the ramping up of crews to full operational levels by quarter end and drilling commenced in October 2026. The drilling campaign includes four approved wells with the potential to add several additional wells that are currently unapproved.

In October 2026, through our Equipment Rental division, we completed the delivery of one of our modular 100-bed remote site camps to a customer on dry-hire for a 2-year minimum term. We have increased the deployment of other rental equipment across the quarter and the outlook for Q4 is for continued growth from both equipment rentals and fire services. We are buoyed by the ongoing demand for these services and the negotiation of several minor services contracts across these revenue streams which have the added benefit of being within adjacent industries such as mining and industrial construction. Exposure to these adjacent industries is a key aspect of the Corporation’s diversification strategy. We aim to leverage the beachheads captured at these new mine sites by marketing other solutions High Arctic can deliver to address our customers challenges and aspirations.

In Q2, we announced appointment as the sole authorized distributor of Atlas Copco Power Technique products for Papua New Guinea, as a key part of our diversification strategy. Supported by Atlas Copco’s regional technical specialists, High Arctic is following up several exciting opportunities for deployment of Atlas Copco Power Technique products. High Arctic is well positioned to provide in-country sales, rentals & after-market solutions and compete for a significant share of the current sizeable and expanding PNG light equipment market.

The Papua-LNG project continues to move closer to FID. The Project Development Forum recently concluded with an agreement reached on benefit sharing in the provinces directly impacted by the project. Project partners have recently reaffirmed that the project is on schedule for a final investment decision in the fourth quarter of 2026 after securing key regulatory approvals and fiscal concessions. The PNG Government have stated that the fiscal concessions are dependent upon an FID taken by December 15, 2026. The Corporation drilled the last 4 appraisal wells in the Antelope gas field, which will be the primary gas source for the project. We expect High Arctic to offer a highly competitive and compelling case for drilling the Papua-LNG development wells.

While there is currently substantive market volatility, circumstances appear favourable for international commodity pricing into the future and PNG presents an attractive proven and secure supply source for Asian buyers seeking alternatives to sources impacted by war or sanctions. This should provide the Corporation’s customers with confidence in a healthy return on the cost of developing both new and backfill production.

Business Strategy
Our rationale for a business strategy focussed on PNG is unchanged. Papua New Guinea possesses substantial deposits of natural resources including significant reserves of oil and natural gas and has emerged as a reliable low-cost energy exporter to Asian markets, particularly for liquefied natural gas (“LNG”). A significant investment in the country’s oil and gas industry was evidenced by the successful construction of the PNG-LNG project in 2014, with the primary partners in the venture being customers of the Corporation. In the period following, the Corporation’s predecessor company committed to the purchase and upgrade of drilling rigs 115 and 116 and expansion of the Corporation’s fleet of rentable equipment including camps, material handling equipment and worksite matting. These investments contributed to a substantive lift in revenues and earnings as PNG enjoyed its highest period of exploration and development activity.

Since the onset of COVID-19 in early 2020, there has been a substantive reduction in drilling services in PNG. This follows some consolidation among the active exploration and production companies and evolving political and economic influences. In the longer term, High Arctic believes PNG is on the precipice of a new round of large-scale projects in the natural resources sector. ‎There is an expectation for increased drilling activity through the latter half of this decade, ‎not only to develop wells for the supply of gas to the Papua-LNG export facility, but also to explore for and ‎appraise other discoveries. The Corporation is strategically positioned to support these developments, given its dominant position for drilling and associated services in PNG, existing work relationships with the operating companies, and proximity to the proposed sites of operation. The Corporation’s drilling rigs 115 and 116 are portable by helicopter and have been maintained and preserved for future use.

There are a number of other petroleum and mining projects and substantive nation-building projects including infrastructure, ‎electrification, telecommunications and defence projects planned for the development of PNG. ‎These ‎projects will require access to transport and material handling machinery, both temporary and permanent power generation assets, quality worksite and temporary ‎road mats and personnel. ‎High Arctic’s business continues to position itself to be a meaningful supplier of services and equipment for this market.

Reflecting upon 2025 and our views on the emerging PNG market, we identified a substantive appetite beyond our traditional customers for in-country solutions for the provision of rental equipment and fire services, particularly in the mining sector and for the provision of reliable power generation equipment, for which we are experiencing demand beyond our capacity to supply. Agreeing terms to become the authorized distributor of Atlas Copco Power Technique products in PNG positions us well to meet these demands both in terms of sales and equipment rentals. We are currently focussed on investing in the renewal and expansion of our rental equipment fleet to meet these needs. We have found fire services in PNG to be under-serviced and we are focussed on expanding our capacity and adding depth to our team with an aim of becoming the premier provider of fire safety solutions in PNG. We believe that this renewed focus will deliver our diversification goals and will provide a solid, profitable and sustainable business foundation in the absence of continuous drilling activity.

Non-IFRS Measures
This Press Release contains references to certain financial measures that do not have a standardized meaning prescribed by International Financial Reporting Standards (“IFRS”) and may not be comparable to the same or similar measures used by other companies. High Arctic uses these financial measures to assess performance and believes these measures provide useful supplemental information to shareholders and investors. These financial measures are computed on a consistent basis for each reporting period and include Oilfield services operating margin, EBITDA (Earnings before interest, tax, depreciation and amortization), Adjusted EBITDA, Operating loss, Funds flow from operating activities, Working capital and Net cash. These do not have standardized meanings.

These financial measures should not be considered as an alternative to, or more meaningful than, net income (loss), cash from operating activities, current assets or current liabilities, cash and/or other measures of financial performance as determined in accordance with IFRS.

For additional information regarding non-IFRS measures, including their use to management and investors and reconciliations to measures recognized by IFRS, please refer to the Corporation’s Q3 2026 MD&A, which is available online at www.sedarplus.ca.

About High Arctic ‎Overseas Holdings Corp.
High Arctic delivers drilling, equipment rentals, fire protection services, asset management and workforce solutions across Papua New Guinea. Together, we combine international standards with local expertise and an unwavering focus on quality, to support oil and gas, mining, and infrastructure projects nationwide.

For further information, please contact:

Matt Cocks 
Chief Financial Officer
1.587.320.1301

High Arctic Overseas Holdings Corp.
801 6 Ave SW Suite 1650, 
Calgary, Alberta, Canada T2P 3W2
www.higharctic.com
Email: info@higharctic.com

Forward-Looking Statements 
This press release contains forward-looking statements and forward-looking information (collectively, “forward-looking statements”) within the meaning of applicable securities laws. Forward-looking statements are based on management’s current expectations, estimates, projections, beliefs and assumptions as of the date of this press release. Forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements.

Forward-looking statements are often identified by words such as “may”, “will”, “would”, “could”, “should”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect”, “forecast”, “project”, “seek”, “continue”, “target”, “aim”, “potential” and similar expressions. In this MD&A, forward-looking statements include, among other things, statements regarding the outlook for the energy services industry in Papua New Guinea (“PNG”); the timing, scope and level of customer drilling, development and other project activity in PNG; the ramp-up of Rig 103 crews to full operational levels and the scope of the current drilling campaign, including four approved wells and the potential for additional wells that are currently unapproved; the potential deployment of other drilling assets; the deployment of the Corporation’s camp assets and rental equipment into new and existing customer operations; the growth and diversification of the Corporation’s Equipment Rentals, Fire Services and other business activities, including expected continued growth in Q4 2026; opportunities arising from the Corporation’s Atlas Copco distributorship and other strategic initiatives; the timing and impact of major resource and infrastructure projects in PNG, including Papua LNG (including the timing of a final investment decision, which the PNG Government has stated must be taken by December 15, 2026 for fiscal concessions to apply) and other natural resource developments; customer demand, commodity prices, foreign exchange rates, liquidity, working capital and capital allocation decisions (including the potential renewal of a Normal Course Issuer Bid); the continued receipt of Bank of PNG and PNG Internal Revenue Commission approvals; the Corporation’s ability to execute its strategic objectives, pursue growth opportunities and maintain adequate financial resources; and the anticipated impact of new accounting standards, including IFRS 18.

  • volatility in crude oil, natural gas and LNG prices
  • delays in the deployment or underutilization of drilling, rental and camp assets
  • reliance on a limited number of significant customers and concentration of accounts receivable
  • risks associated with diversification initiatives and new business opportunities
  • geopolitical events, including conflicts in the Middle East and Ukraine, trade restrictions and global economic uncertainty
  • cybersecurity risks
  • inflationary pressures and supply chain constraints and labour availability
  • access to capital and liquidity risk.
  • uncertainty regarding customer activity and future project approvals, including delay or failure of Papua LNG to reach a final investment decision
  • severe weather conditions, including prolonged dry weather that limits river freight transport in PNG
  • foreign exchange volatility and PNG foreign currency restrictions, including Bank of PNG approvals for USD settlement and restrictions on repatriating funds
  • changes in government policy, taxation, environmental and climate-related regulation
  • risks associated with tenders, acquisitions and other strategic or expansionary transactions
  • operational, safety, environmental and legal risks, including the outcome of ongoing legal proceedings.

Additional risks and uncertainties are described elsewhere in this press release under “Business Risks and Uncertainties” and “Financial Risk Management” of the Corporation’s Q3 2026 MD&A.

In preparing the forward-looking statements contained in this press release, the Corporation has made assumptions including, without limitation, assumptions regarding: customer demand, commodity prices, the timing of project activity in PNG, the availability and performance of equipment and personnel, the successful execution of strategic initiatives, the availability of goods and services on commercially reasonable terms, the Corporation’s ability to obtain required regulatory approvals, manage foreign exchange exposures and maintain adequate liquidity.

Although the Corporation believes that the expectations reflected in these forward-looking statements and the assumptions on which they are based are reasonable, there can be no assurance that such expectations or assumptions will prove to be correct. Actual results may differ materially from those expressed or implied by forward-looking statements as a result of the factors discussed above and elsewhere in this press release, and in the risk factors set forth in the Corporation’s Listing Application dated August 12, 2024, which is available on SEDAR+.

The forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. These statements are given only as of the date of this press release. The Corporation does not assume any obligation to update these forward-looking statements to reflect new information, subsequent events or otherwise, except as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the ‎policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Black Friday offer and holiday promo codes aimed at the half of U.S. shoppers planning to give an experience this season

FORT WORTH, Texas, Nov. 20, 2026 (GLOBE NEWSWIRE) — Sports Entertainment Gaming Global Corporation (“SEGG Media” or the “Company”) (Nasdaq: SEGG) today announced that TicketStub.com will relaunch on a new platform on November 25, at the start of the holiday shopping season. TicketStub.com will open with a Black Friday offer, with details to be announced closer to launch, and will release promo codes for discounted tickets throughout the holidays.

Half of U.S. holiday shoppers plan to give an experience this year, up from 39% in 2024, and 19% plan to give tickets to an event, according to Deloitte’s 2026 Holiday Retail Survey. The same survey found that 47% of shoppers would rather give one meaningful, higher-cost gift than several smaller ones. On the receiving side, concert tickets ranked second only to a full trip among the experiences Americans most wanted as a holiday gift, cited by 51% of respondents in a 2025 Talker Research survey of 5,000 adults commissioned by Chime.

Demand for live events is running at record levels. Live Nation Entertainment reported selling 170 million concert tickets through October 2026, up 13% year over year and already ahead of its total for all of 2025.

TicketStub.com gives users access to thousands of events around the world and earns revenue through service fees. The Company plans to add advertising and promoted listings as the platform develops. The relaunch follows the worldwide relaunch of Lottery.com on November 18 and is supported by the strategic financing commitments SEGG Media announced on November 12.

“Veloce’s channels draw more than 500 million views a month from fans who follow racing, gaming and live sport. That’s an audience that goes to live events, and putting TicketStub.com in front of them is our first priority,” said Gregory Potts, Chief Operating Officer of SEGG Media. “We also plan to add an ongoing sweepstakes where users can win free tickets, concert experiences and other live event prizes. Along with the Black Friday offer and holiday promo codes, it gives fans a reason to keep coming back to TicketStub.com.”

About SEGG Media Corporation

SEGG Media (Nasdaq: SEGG, LTRYW) is a global sports, entertainment, and gaming group operating a portfolio of digital assets including Sports.com, Concerts.com, TicketStub.com, Lottery.com, and Veloce Media Group. Focused on immersive fan engagement, ethical gaming, and AI-driven live experiences, SEGG Media is redefining how global audiences interact with the content they love.

Important Notice Regarding Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding the expected timing of the TicketStub.com relaunch, the planned Black Friday offer and holiday promotions, the expected revenue model of the platform, the planned addition of advertising and promoted listings, the planned sweepstakes, the Company’s plans to reach Veloce Media Group audiences, and the availability and deployment of financing to support the rollout. Third-party market and survey data cited in this press release have not been independently verified by the Company. These forward-looking statements are based on management’s current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially, including, among others: delays in platform development, testing or launch; the Company’s ability to secure ticket inventory and enter into and maintain ticketing, payment and commercial partnerships; customer adoption of the platform; the Company’s ability to offer the planned sweepstakes in compliance with applicable federal, state and international laws; competition from larger, established ticket marketplaces; changes in consumer spending and demand for live events; the Company’s ability to secure, close and deploy the anticipated financing; the Company’s need for additional capital and its ability to obtain financing on acceptable terms, which may include financing that dilutes existing shareholders; the Company’s ability to continue as a going concern; the Company’s ability to maintain compliance with Nasdaq Listing Rules and remain current with its SEC reports; and the other risks and uncertainties described under “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, its subsequent Quarterly Reports on Form 10-Q, and its other filings with the SEC. These forward-looking statements speak only as of the date of this press release. Except as required by law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

This press release was published by a CLEAR® Verified individual.

CONTACT: For additional information
SEGG Media
press@seggmedia.com
737-587-3391
SEGG Investors
ir@seggmedia.com
737-787-3891

BANGKOK, Nov. 20, 2026 (GLOBE NEWSWIRE) — NewGenIvf Group Limited (NASDAQ: NIVF) (the “Company”), a technology-driven, diversified growth company, today announced the closing of its previously announced firm commitment underwritten offering with gross proceeds to the Company of approximately $2.5 million, before deducting underwriting fees and other offering expenses payable by the Company.

The offering consisted of 71,428,570 Class A Ordinary Shares (or pre-funded warrants to purchase Class A Ordinary Shares in lieu thereof (the “Pre-Funded Warrants”)). At closing, the offering comprised 9,501,148 Class A Ordinary Shares and Pre-Funded Warrants to purchase up to 61,927,422 Class A Ordinary Shares. The offering price per Class A Ordinary Share was $0.035 (or $0.03499 for each Pre-Funded Warrant, which is equal to the offering price per Class A Ordinary Share sold in the offering minus an exercise price of $0.00001 per Pre-Funded Warrant). The Pre-Funded Warrants are immediately exercisable and may be exercised at any time until exercised in full. For each Pre-Funded Warrant sold in the offering, the number of Class A Ordinary Shares in the offering will be decreased on a one-for-one basis.

Aggregate gross proceeds to the Company were approximately $2.5 million. The transaction closed on November 20, 2026. The Company expects to use the net proceeds from the offering, together with its existing cash, for commercialization and expansion of the Nodexus advanced cytometry technology and our assisted reproductive services platform, further strategic investments in prediction-market and digital-asset/AI initiatives, our real estate interests in the UAE, and other general corporate purposes. Our management will retain broad discretion to apply these net proceeds. We will also apply approximately $625,000 of the gross proceeds of this offering to repurchase $584,112 in principal amount of the Exchange Note. The Company’s Class A Ordinary Shares are listed on the Nasdaq Capital Market under the symbol “NIVF”.

Aegis Capital Corp. acted as the sole book-running manager for the offering. Han Kun Law Offices LLP acted as U.S. counsel to the Company. Kaufman & Canoles, P.C. acted as U.S. counsel to Aegis Capital Corp.

The offering was made pursuant to an effective shelf registration statement on Form F-3 (No. 333-299649) previously filed with the U.S. Securities and Exchange Commission (SEC) and declared effective by the SEC on November 12, 2026. A final prospectus supplement and accompanying prospectus describing the terms of the offering have been filed with the SEC and are available on the SEC’s website located at www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained by contacting Aegis Capital Corp., Attention: Syndicate Department, 1345 Avenue of the Americas, 27th floor, New York, NY 10105, by email at syndicate@aegiscap.com, or by telephone at +1 (212) 813-1010.

Interested parties should read in their entirety the prospectus supplement and the accompanying prospectus and the other documents that the Company has filed with the SEC that are incorporated by reference in such prospectus supplement and the accompanying prospectus, which provide more information about the Company and the offering.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About NewGenIvf Group Limited

NewGenIvf Group Limited is a technology-forward, diversified growth company pursuing opportunities across real estate development, digital asset innovation, and reproductive health solutions. The Company operates through NewGenProperty, focused on real estate development projects in Ras Al Khaimah, United Arab Emirates; NewGenDigital, focused on digital asset and decentralized-finance solutions; and NewGenSup, focused on health and longevity products and solutions. The Company’s legacy business includes IVF and assisted reproductive treatment services across Asia. To learn more, visit www.nivf.global. Information contained on, or accessible through, the Company’s website is not incorporated by reference into this press release.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation statements regarding the anticipated use of proceeds from the offering, the Company’s product development and business prospects, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of risks and uncertainties that could significantly affect current plans. Should one or more of these risks or uncertainties materialize, or the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, performance, or achievements. For a discussion of the risks and uncertainties that could cause actual results to differ materially, see the section entitled “Risk Factors” in the Company’s Annual Report on Form 20-F for the year ended December 31, 2025 and in the final prospectus supplement relating to the offering. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

Investor Contact:
ICR, LLC
Robin Yang
Phone: +1 (212) 537-4406
Email: Newgenivf.IR@icrinc.com

Friday, November 20, 2026


Dear Shareholders and Investors,

Nordic American Tankers Limited (NYSE:NAT) conducted its Annual General Meeting of Shareholders (the “Meeting”) today, on November 20, 2026.

We experienced the highest turnout for years at this AGM and all resolutions were approved and adopted at the Meeting:
Election of Herbjorn Hansson, Alexander Hansson, Jenny Chu and Jim Kelly to serve as Directors of the Board.

Approval of the appointment of KPMG as the Company’s independent auditors.

We are in a strong market and prospects are good.

For further information on Nordic American Tankers, please see www.nat.bm 

Sincerely,

Herbjorn Hansson
Founder, Chairman & CEO
Nordic American Tankers Ltd.                                                        www.nat.bm

 

 Contacts:       

Bjørn Giæver, CFO                                                             
Nordic American Tankers Ltd                                             
Tel: +1 888 755 8391                                  

Alexander Kihle, Finance Manager
Nordic American Tankers Ltd
Tel: +47 91 724 171    

AB “Ignitis grupė” (hereinafter – the Group) informs that the Group’s Supervisory Board and Management Board have given their final approval to the appointment of Vytenis Koryzna as Chair of the Management Board and CEO of the Group. The new CEO’s term of office will begin on 1 January 2027. V. Koryzna is already a member of the Group’s Management Board, and the handover of duties and responsibilities is progressing faster than planned and will be completed by the end of the current financial year, rather than 1 March 2027, as previously planned.

Accordingly, the second and final term of the Group’s current CEO, D. Maikštėnas, will end on 31 December 2026, instead of 28 February 2027, as previously planned.

“In March this year, we re-elected Darius Maikštėnas as Chair of the Management Board and CEO of the Group, setting two key objectives: to ensure the successful implementation of the Group’s strategic initiatives, as well as a smooth handover process, by the end of his second term. On behalf of the Supervisory Board, I thank Darius for ensuring that these objectives were achieved smoothly. With the leadership handover progressing successfully, the new CEO will be able to take responsibility for the Group and the delivery of its 2027 objectives from the very beginning of the financial year,” says Alfonso Faubel, Chair of the Supervisory Board of Ignitis Group.

“Over the past decade, Lithuania and the entire region have undergone an energy transformation that has ended chronic dependence on energy imports and fundamentally modernized the entire energy ecosystem. These changes are now irreversible. I am grateful to everyone at Ignitis Group for contributing to this transformation together and building one of the most advanced energy groups in the region – an example for many organizations. Having joined the Group this year, Vytenis has had the opportunity not only to familiarize himself with the specifics of all the Group’s businesses, but also to experience the culture of its people. Today, the organization stands on solid foundations, has a clear direction for the future and is ready to move forward with confidence next year,” says Darius Maikštėnas, Chair of the Management Board and CEO of the Group.

The Group reminds that the selection process for a member of the Group’s Management Board responsible for the energy market and commerce area of competence is currently underway. The selected Management Board member will take over the area of competence currently overseen by V. Koryzna after he assumes the duties of CEO and Chair of the Management Board of the Group.

Communications
Valdas Lopeta
+370 621 77993
valdas.lopeta@ignitis.lt

AB “Ignitis grupė” (hereinafter – the Group) informs that the Group’s Supervisory Board and Management Board have given their final approval to the appointment of Vytenis Koryzna as Chair of the Management Board and CEO of the Group. The new CEO’s term of office will begin on 1 January 2027. V. Koryzna is already a member of the Group’s Management Board, and the handover of duties and responsibilities is progressing faster than planned and will be completed by the end of the current financial year, rather than 1 March 2027, as previously planned.

Accordingly, the second and final term of the Group’s current CEO, D. Maikštėnas, will end on 31 December 2026, instead of 28 February 2027, as previously planned.

“In March this year, we re-elected Darius Maikštėnas as Chair of the Management Board and CEO of the Group, setting two key objectives: to ensure the successful implementation of the Group’s strategic initiatives, as well as a smooth handover process, by the end of his second term. On behalf of the Supervisory Board, I thank Darius for ensuring that these objectives were achieved smoothly. With the leadership handover progressing successfully, the new CEO will be able to take responsibility for the Group and the delivery of its 2027 objectives from the very beginning of the financial year,” says Alfonso Faubel, Chair of the Supervisory Board of Ignitis Group.

“Over the past decade, Lithuania and the entire region have undergone an energy transformation that has ended chronic dependence on energy imports and fundamentally modernized the entire energy ecosystem. These changes are now irreversible. I am grateful to everyone at Ignitis Group for contributing to this transformation together and building one of the most advanced energy groups in the region – an example for many organizations. Having joined the Group this year, Vytenis has had the opportunity not only to familiarize himself with the specifics of all the Group’s businesses, but also to experience the culture of its people. Today, the organization stands on solid foundations, has a clear direction for the future and is ready to move forward with confidence next year,” says Darius Maikštėnas, Chair of the Management Board and CEO of the Group.

The Group reminds that the selection process for a member of the Group’s Management Board responsible for the energy market and commerce area of competence is currently underway. The selected Management Board member will take over the area of competence currently overseen by V. Koryzna after he assumes the duties of CEO and Chair of the Management Board of the Group.

Communications
Valdas Lopeta
+370 621 77993
valdas.lopeta@ignitis.lt

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.